Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atamestane and Toremifene in Metastatic Breast Cancer
NCT00010322Phase 3Terminated
- Sponsor
- Intarcia Therapeutics
- Start
- Oct 2000
- Primary completion
- May 2001
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of atamestane in breast cancer, sponsored by Intarcia Therapeutics. Started Oct 2000; status: terminated.
02
Drugs
atamestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00010322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010322.